Search the Newsreel

Fabrinet schedules Aug. 18 fireside chat at AI summit

Fabrinet (FN) announced its management will participate in the Rosenblatt 6th Annual Age of AI Technology Summit, hosting a fireside chat on Tuesday, August 18, 2026, at 1:00 p.m. EDT. The event will be available via live and replay webcasts on the company's investor …

Fabrinet to Present at the Rosenblatt 6th Annual Age of AI Technology Summit

Fabrinet announced that its management will present at the Rosenblatt 6th Annual Age of AI Technology Summit. The fireside chat is scheduled for Tuesday, August 18, 2026, at 1:00 p.m. EDT. A live webcast and replay will be available on the company's investor relations …

Fortinet Inc. stock outperforms competitors despite losses on the day

Fortinet Inc. (FTNT) shares fell 1.41% to $161.89 on Tuesday, despite outperforming the broader market, which also experienced losses. The S&P 500 Index and Dow Jones Industrial Average both declined. Fortinet's stock is currently 5.93% below its 52-week high.

Alert: Unpatched Fortinet Devices Fall to Gunra Ransomware

A joint alert from U.S. and South Korean cybersecurity agencies warns that the Gunra ransomware-as-a-service operation is actively exploiting unpatched Fortinet devices, specifically VPN gateways and firewall appliances. The attackers are targeting known vulnerabilities, some of which Fortinet patched in early 2025, to gain …

Crinetics Pharmaceuticals stock hits all-time high at 84.35 USD

Crinetics Pharmaceuticals (CRNX) stock reached an all-time high of $84.35, reflecting a 196.14% increase over the past year and a current market capitalization of approximately $8.94 billion. Despite its strong performance, InvestingPro data suggests the stock might be overbought and overvalued. The company recently …

Curreen Capital: TriNet (TNET) is a “Crazy-Cheap” Turnaround

Investment management company Curreen Capital released its second-quarter 2026 Investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.26% compared to 15.20% for the S&P 500 Index. The performance was driven by active special case …

Cytokinetics president & CEO Robert Blum sells $575,700 in shares

Robert I. Blum, President and CEO of Cytokinetics Inc. (NASDAQ:CYTK), sold 7,500 shares of common stock for $575,700, while also acquiring 7,500 shares through option exercise for $79,500. Following these transactions, Blum directly holds 377,820 shares, with additional indirect holdings. This comes as CYTOKINETICS …

E. Ohman J or Asset Management AB Cuts Stock Position in Fortinet, Inc. $FTNT

E. Ohman J or Asset Management AB reduced its stake in Fortinet, Inc. (NASDAQ:FTNT) by 10.3% in the second quarter, selling 29,440 shares and now holding 255,619 shares valued at $39.27 million. Other institutional investors showed mixed activity, with some increasing and others initiating …

Bank of America Corp DE Has $65.55 Million Position in Fabrinet $FN

Bank of America Corp DE increased its stake in Fabrinet (NYSE:FN) by 40.8% in the first quarter, now holding 125,683 shares valued at approximately $65.55 million. Institutional investors own 97.38% of Fabrinet's shares, with analysts giving the stock a "Moderate Buy" consensus rating and …

Upgrade: Analysts Just Made A Notable Increase To Their Kinetik Holdings Inc. (NYSE:KNTK) Forecasts

Analysts have significantly upgraded their statutory revenue and earnings per share forecasts for Kinetik Holdings Inc. (NYSE:KNTK) for 2026, now expecting revenues of US$2.1 billion and EPS of US$1.20. Despite the positive outlook and accelerated growth expectations compared to the industry, the consensus price …

Do Fabrinet’s (FN) Mixed Earnings Signals Clarify or Cloud Its Long-Term Growth Narrative?

Fabrinet (FN) is attracting attention ahead of its June 2026 quarterly results, with analysts anticipating higher year-over-year earnings. Despite a positive Earnings ESP, a Zacks Rank of #4 indicates investor uncertainty. The company's growth narrative relies on its role in high-speed optical and AI …

Fabrinet (FN) Stock Looks Fully Priced As Growth Expectations Stay High

Fabrinet (FN) has seen a significant 389.1% return over the past 5 years, but its current share price of US$455.94 appears overvalued based on a Discounted Cash Flow (DCF) estimate, which suggests an intrinsic value of about $315 per share. While earnings-based valuations indicate …

Kinetik Holdings (KNTK) holder ISQ Global Fund II plans large Class A share sale

ISQ Global Fund II GP LLC has filed a Form 144 to sell 80,442,263 shares of Kinetik Holdings Inc. (KNTK) Class A Common Stock, valued at approximately $4,023,361.98. The sale will be executed through Goldman Sachs & Co. LLC on the NYSE, with the …

Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells $575,700.00 in Stock

Cytokinetics CEO Robert Blum sold 7,500 shares of the company's stock for $575,700, reducing his direct holdings by 1.95%. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Despite the insider selling, analysts generally maintain a "Moderate Buy" rating for CYTK with …

Kinetik Holdings (KNTK) COO receives 12,164 RSUs and new PSU dividend units

Kinetik Holdings Inc. COO Matthew Wall was granted 12,164 restricted stock units (RSUs) and accrued 1,939 dividend equivalent performance share units (PSUs). These equity awards were granted under the company's Amended and Restated 2019 Omnibus Compensation Plan, with the RSUs generally vesting on July …

Kinetik Holdings (NYSE: KNTK) CFO receives RSU grant and dividend PSUs

Kinetik Holdings Inc. (NYSE: KNTK) CFO Howard Trevor was granted 10,846 restricted stock units (RSUs) vesting on July 31, 2028, and accrued 1,150 dividend equivalent Performance Share Units (PSUs) tied to a prior grant. Following these awards, Trevor directly holds 260,641 shares of Class …

Kinetik Holdings (KNTK) grants RSUs and PSUs to General Counsel Ellis Lindsay

Kinetik Holdings Inc. has granted 9,731 restricted stock units (RSUs) and 578 dividend-equivalent performance share units (PSUs) to its General Counsel, Ellis Lindsay. The RSUs are set to vest on July 31, 2028, contingent on continued service, while the PSUs are dividend equivalents accrued …

Cytokinetics, Incorporated Revenue Breakdown – NASDAQ:CYTK

Cytokinetics, Incorporated (NASDAQ: CYTK) generated $88.04 million USD in revenue last year, primarily from its Muscle Activators and Muscle Inhibitors segment. This represents a significant increase from the previous year's $18.47 million USD. The United States was the greatest contributor to this revenue.

Fortinet Inc Stock (FTNT) Moved Up by 3.35% on Aug 10: A Full Analysis

Fortinet Inc. (FTNT) saw its stock rise by 3.35% on August 10, outperforming the Software & IT Services sector. This surge is attributed to the company exceeding institutional expectations in quarterly billings and free cash flow margins, driven by a strategic shift towards software-defined …

Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Firefly Aerospace Inc. (FLY), Flywire Corporation (FLYW), Fortinet, Inc. (FTNT), and Compass Diversified Holdings (CODI)

Johnson Fistel, PLLP has initiated investigations into potential claims of breach of fiduciary duty against officers and directors of Firefly Aerospace Inc. (FLY), Flywire Corporation (FLYW), Fortinet, Inc. (FTNT), and Compass Diversified Holdings (CODI). The investigations target alleged misrepresentations and failures that led to …

Kinetic Development Group (SEHK:1277) Brings Makhado Online Following MC Mining Deal As Valuation Debate Builds

Here’s How Much You Would Have Made Owning Fabrinet Stock In The Last 10 Years

Fabrinet (NYSE: FN) has significantly outperformed the market over the last decade, with an annualized return of 29.56%, surpassing the market by 16.06%. An initial investment of $1000 in FN stock 10 years ago would now be worth over $12,500. This demonstrates the powerful …

Fabrinet shares may swing 12% on Aug. 17 earnings release

Fabrinet shares are predicted to swing by 12% following its earnings release on August 17, according to options data. Historically, the stock's actual movement has often differed from the implied volatility suggested by options trading, sometimes exceeding and other times falling short of the …

Fabrinet (FN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The market expects Fabrinet (FN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence …

CYTOKINETICS, INCORPORATED : LEERINK PARTNERS RAISES TARGET PRICE TO $103 FROM $100

LEERINK PARTNERS has increased its target price for CYTOKINETICS, INCORPORATED (CYTK.O) from $100 to $103. The article is a brief financial news update from Reuters, indicating a positive analyst sentiment towards the company. It notes that the content reflects only the author's opinion and …

Vista Investment Partners LLC Increases Holdings in Fortinet, Inc. $FTNT

Vista Investment Partners LLC significantly increased its stake in Fortinet, Inc. by 53.1% in the second quarter, now owning 49,058 shares valued at approximately $7.5 million. This increase makes Fortinet the 11th largest holding in Vista Investment Partners' portfolio. The cybersecurity company recently reported …

Royal Bank Of Canada Issues Positive Forecast for QinetiQ Group (LON:QQ) Stock Price

Hennion & Walsh Asset Management Inc. Trims Stake in Fortinet, Inc. $FTNT

Hennion & Walsh Asset Management Inc. reduced its stake in Fortinet, Inc. by 16.4% in the second quarter, selling 6,889 shares and holding 35,134 shares valued at $5.4 million. Despite strong quarterly earnings where Fortinet beat estimates, insider selling activity totaling $69.5 million over …

Fabrinet (FN) to Release Quarterly Earnings on Monday

Kinetic Development Expects Up to 40% Rise in Interim Profit; Shares Jump 9%

Kinetic Development Forecasts Up to 40% Profit Surge on Stronger Coal Prices and Cost Cuts

First Trust Advisors LP Raises Stake in Crinetics Pharmaceuticals, Inc. $CRNX

First Trust Advisors LP increased its stake in Crinetics Pharmaceuticals (CRNX) by 54.9% in the first quarter, now holding 51,365 shares valued at $1.87 million. Despite insider stock sales, the company reported strong Q1 earnings, beating revenue estimates by 2336.9% year-over-year. Analysts have a …

Fortinet Inc (FTNT) Stock News Today

This article provides a list of recent news updates regarding Fortinet Inc (FTNT) stock performance from TradingKey. It details several instances of the stock moving up or down by significant percentages on specific dates, offering a historical overview of its short-term volatility. The updates …

Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Cytokinetics, Incorporated (NASDAQ:CYTK) on behalf of investors who purchased securities before December 27, 2023. The investigation seeks to determine if the company or its officers engaged in corporate wrongdoing. The law firm is encouraging …

Is Fortinet (FTNT) Fully Valued On Its Raised 2026 Revenue Guidance?

Kinetik Holdings Inc. $KNTK Shares Sold by Pacer Advisors Inc.